| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Replacement Therapy | 188 | 2024 | 1206 | 24.050 |
Why?
|
| Postmenopause | 388 | 2024 | 2509 | 22.040 |
Why?
|
| Women's Health | 305 | 2024 | 2056 | 20.460 |
Why?
|
| Menopause | 126 | 2024 | 1640 | 16.780 |
Why?
|
| Vitamin D | 152 | 2024 | 3291 | 13.210 |
Why?
|
| Dietary Supplements | 178 | 2024 | 3392 | 12.470 |
Why?
|
| Estrogens, Conjugated (USP) | 86 | 2024 | 275 | 12.180 |
Why?
|
| Fatty Acids, Omega-3 | 76 | 2024 | 1387 | 11.920 |
Why?
|
| Cardiovascular Diseases | 355 | 2024 | 15757 | 11.160 |
Why?
|
| Cholecalciferol | 51 | 2024 | 550 | 9.840 |
Why?
|
| Vitamins | 91 | 2024 | 1634 | 9.000 |
Why?
|
| Estrogens | 89 | 2024 | 1520 | 8.450 |
Why?
|
| Hormone Replacement Therapy | 52 | 2024 | 755 | 8.380 |
Why?
|
| Coronary Disease | 188 | 2024 | 5990 | 7.940 |
Why?
|
| Diabetes Mellitus, Type 2 | 260 | 2024 | 12293 | 7.500 |
Why?
|
| Vitamin D Deficiency | 44 | 2024 | 1379 | 7.050 |
Why?
|
| Medroxyprogesterone Acetate | 45 | 2024 | 155 | 5.630 |
Why?
|
| Diet | 177 | 2024 | 8010 | 5.120 |
Why?
|
| Hot Flashes | 36 | 2024 | 328 | 5.010 |
Why?
|
| Risk Factors | 818 | 2024 | 74359 | 4.750 |
Why?
|
| Female | 1478 | 2024 | 391270 | 4.580 |
Why?
|
| Middle Aged | 1158 | 2024 | 220352 | 4.260 |
Why?
|
| Body Mass Index | 262 | 2024 | 12914 | 4.220 |
Why?
|
| Calcium, Dietary | 32 | 2024 | 531 | 4.140 |
Why?
|
| Prospective Studies | 640 | 2024 | 54303 | 3.870 |
Why?
|
| Incidence | 363 | 2024 | 21392 | 3.860 |
Why?
|
| Aged | 848 | 2024 | 169152 | 3.830 |
Why?
|
| Obesity | 167 | 2024 | 12922 | 3.790 |
Why?
|
| Humans | 1739 | 2024 | 760621 | 3.790 |
Why?
|
| Breast Neoplasms | 156 | 2024 | 21025 | 3.550 |
Why?
|
| Premenstrual Syndrome | 15 | 2019 | 107 | 3.430 |
Why?
|
| Exercise | 122 | 2024 | 5787 | 3.380 |
Why?
|
| Double-Blind Method | 169 | 2024 | 12427 | 3.370 |
Why?
|
| Proportional Hazards Models | 237 | 2024 | 12531 | 3.250 |
Why?
|
| Estradiol | 44 | 2023 | 1932 | 3.200 |
Why?
|
| Vitamin B 6 | 16 | 2018 | 233 | 3.200 |
Why?
|
| Calcium Carbonate | 16 | 2021 | 62 | 3.170 |
Why?
|
| Primary Prevention | 33 | 2022 | 1207 | 3.140 |
Why?
|
| Vitamin B 12 | 16 | 2018 | 522 | 3.030 |
Why?
|
| Life Style | 92 | 2024 | 3896 | 2.950 |
Why?
|
| Randomized Controlled Trials as Topic | 109 | 2024 | 10344 | 2.910 |
Why?
|
| Folic Acid | 27 | 2018 | 1309 | 2.910 |
Why?
|
| Ovariectomy | 16 | 2023 | 611 | 2.900 |
Why?
|
| Calcium | 43 | 2024 | 5725 | 2.860 |
Why?
|
| Menopause, Premature | 13 | 2023 | 125 | 2.830 |
Why?
|
| Aspirin | 65 | 2022 | 3364 | 2.780 |
Why?
|
| Follow-Up Studies | 352 | 2024 | 39261 | 2.720 |
Why?
|
| United States | 466 | 2024 | 72461 | 2.680 |
Why?
|
| Hysterectomy | 28 | 2024 | 904 | 2.620 |
Why?
|
| Weight Gain | 60 | 2023 | 2347 | 2.590 |
Why?
|
| Nurses | 70 | 2023 | 2467 | 2.560 |
Why?
|
| Fractures, Bone | 23 | 2024 | 2041 | 2.540 |
Why?
|
| Stroke | 94 | 2024 | 9962 | 2.470 |
Why?
|
| Neoplasms | 119 | 2024 | 22072 | 2.460 |
Why?
|
| Progestins | 30 | 2022 | 302 | 2.390 |
Why?
|
| Overweight | 46 | 2024 | 2421 | 2.350 |
Why?
|
| Hypertension | 90 | 2024 | 8594 | 2.340 |
Why?
|
| Diabetes Mellitus | 53 | 2024 | 5889 | 2.310 |
Why?
|
| Diabetes, Gestational | 25 | 2024 | 1242 | 2.260 |
Why?
|
| Risk | 169 | 2023 | 9631 | 2.210 |
Why?
|
| Risk Assessment | 152 | 2023 | 24123 | 2.200 |
Why?
|
| Cause of Death | 54 | 2024 | 3725 | 2.030 |
Why?
|
| Cohort Studies | 308 | 2024 | 41335 | 2.020 |
Why?
|
| Cacao | 11 | 2024 | 98 | 1.990 |
Why?
|
| Mortality | 37 | 2024 | 2916 | 1.980 |
Why?
|
| Antioxidants | 34 | 2014 | 1667 | 1.960 |
Why?
|
| Eicosapentaenoic Acid | 14 | 2024 | 613 | 1.940 |
Why?
|
| Female Urogenital Diseases | 3 | 2023 | 57 | 1.930 |
Why?
|
| beta Carotene | 39 | 2024 | 524 | 1.870 |
Why?
|
| Docosahexaenoic Acids | 14 | 2024 | 912 | 1.840 |
Why?
|
| Vitamin E | 34 | 2014 | 872 | 1.840 |
Why?
|
| Adult | 617 | 2024 | 219994 | 1.780 |
Why?
|
| Dietary Fats | 41 | 2023 | 1992 | 1.740 |
Why?
|
| Alcohol Drinking | 75 | 2021 | 4013 | 1.710 |
Why?
|
| Feeding Behavior | 50 | 2024 | 3185 | 1.690 |
Why?
|
| Diet, Fat-Restricted | 16 | 2024 | 330 | 1.650 |
Why?
|
| Depression | 31 | 2024 | 8044 | 1.650 |
Why?
|
| C-Reactive Protein | 61 | 2024 | 3839 | 1.600 |
Why?
|
| Myocardial Infarction | 89 | 2023 | 11891 | 1.600 |
Why?
|
| Waist Circumference | 15 | 2023 | 926 | 1.590 |
Why?
|
| Contraceptives, Oral | 19 | 2022 | 554 | 1.590 |
Why?
|
| Vitamin B Complex | 8 | 2016 | 297 | 1.580 |
Why?
|
| Age Factors | 105 | 2024 | 18416 | 1.570 |
Why?
|
| Vasomotor System | 11 | 2020 | 207 | 1.550 |
Why?
|
| Ascorbic Acid | 21 | 2014 | 655 | 1.540 |
Why?
|
| Motor Activity | 29 | 2015 | 2687 | 1.540 |
Why?
|
| Smoking | 110 | 2023 | 9073 | 1.510 |
Why?
|
| Aging | 44 | 2024 | 8651 | 1.500 |
Why?
|
| Case-Control Studies | 173 | 2024 | 22053 | 1.500 |
Why?
|
| Multivariate Analysis | 160 | 2019 | 12159 | 1.490 |
Why?
|
| Endometrial Neoplasms | 14 | 2022 | 1357 | 1.450 |
Why?
|
| Dementia | 19 | 2024 | 2649 | 1.420 |
Why?
|
| Male | 442 | 2024 | 359744 | 1.400 |
Why?
|
| Sweating | 9 | 2023 | 154 | 1.360 |
Why?
|
| Colorectal Neoplasms | 45 | 2024 | 6853 | 1.360 |
Why?
|
| Parathyroid Hormone | 10 | 2023 | 1797 | 1.340 |
Why?
|
| Parity | 16 | 2024 | 925 | 1.340 |
Why?
|
| Heart Failure | 31 | 2024 | 11847 | 1.320 |
Why?
|
| Dairy Products | 16 | 2021 | 494 | 1.320 |
Why?
|
| Chronic Disease | 31 | 2024 | 9287 | 1.310 |
Why?
|
| Coronary Artery Disease | 28 | 2024 | 6659 | 1.310 |
Why?
|
| Platelet Aggregation Inhibitors | 17 | 2022 | 3201 | 1.290 |
Why?
|
| Fruit | 29 | 2024 | 1160 | 1.260 |
Why?
|
| Respiratory Tract Infections | 3 | 2024 | 1007 | 1.240 |
Why?
|
| Eggs | 6 | 2021 | 183 | 1.240 |
Why?
|
| Inflammation | 48 | 2024 | 10756 | 1.230 |
Why?
|
| Magnesium | 19 | 2020 | 810 | 1.230 |
Why?
|
| Cognition | 42 | 2024 | 6957 | 1.220 |
Why?
|
| Odds Ratio | 79 | 2024 | 9716 | 1.200 |
Why?
|
| Energy Intake | 45 | 2024 | 2129 | 1.190 |
Why?
|
| Vaginal Diseases | 2 | 2019 | 103 | 1.190 |
Why?
|
| Atherosclerosis | 10 | 2024 | 3517 | 1.190 |
Why?
|
| Dietary Carbohydrates | 22 | 2023 | 892 | 1.190 |
Why?
|
| Insulin Resistance | 26 | 2024 | 3959 | 1.180 |
Why?
|
| Menstrual Cycle | 12 | 2022 | 536 | 1.180 |
Why?
|
| Vegetables | 32 | 2024 | 1196 | 1.170 |
Why?
|
| Death, Sudden, Cardiac | 20 | 2019 | 1572 | 1.170 |
Why?
|
| Sweetening Agents | 7 | 2023 | 290 | 1.150 |
Why?
|
| Cholesterol, HDL | 35 | 2024 | 1817 | 1.150 |
Why?
|
| Polymorphism, Single Nucleotide | 58 | 2024 | 15789 | 1.140 |
Why?
|
| Amino Acids, Branched-Chain | 10 | 2022 | 264 | 1.140 |
Why?
|
| Solanum tuberosum | 3 | 2024 | 40 | 1.130 |
Why?
|
| Homocysteine | 15 | 2021 | 640 | 1.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 18 | 2023 | 3334 | 1.120 |
Why?
|
| Body Weight | 43 | 2023 | 4611 | 1.080 |
Why?
|
| Walking | 20 | 2024 | 1189 | 1.070 |
Why?
|
| Hip Fractures | 16 | 2024 | 989 | 1.050 |
Why?
|
| Macular Degeneration | 11 | 2021 | 1002 | 1.040 |
Why?
|
| Adiposity | 20 | 2024 | 1858 | 1.020 |
Why?
|
| Reproductive History | 7 | 2024 | 210 | 1.010 |
Why?
|
| Risk Reduction Behavior | 17 | 2024 | 1109 | 1.010 |
Why?
|
| Bone Density | 15 | 2023 | 3534 | 1.010 |
Why?
|
| Accidental Falls | 5 | 2023 | 1056 | 1.010 |
Why?
|
| Longevity | 13 | 2024 | 1050 | 1.000 |
Why?
|
| Body Composition | 13 | 2023 | 2419 | 0.990 |
Why?
|
| Infertility, Female | 7 | 2023 | 759 | 0.980 |
Why?
|
| Waist-Hip Ratio | 10 | 2021 | 516 | 0.980 |
Why?
|
| Administration, Intravaginal | 7 | 2019 | 151 | 0.960 |
Why?
|
| Women's Health Services | 3 | 2021 | 89 | 0.960 |
Why?
|
| Bone Density Conservation Agents | 7 | 2017 | 796 | 0.950 |
Why?
|
| Health Behavior | 26 | 2019 | 2622 | 0.950 |
Why?
|
| Sterilization, Tubal | 5 | 2024 | 80 | 0.940 |
Why?
|
| Diet, Mediterranean | 13 | 2024 | 735 | 0.940 |
Why?
|
| Breast Feeding | 12 | 2024 | 1355 | 0.930 |
Why?
|
| Osteoporotic Fractures | 7 | 2023 | 409 | 0.920 |
Why?
|
| Aged, 80 and over | 164 | 2024 | 58995 | 0.920 |
Why?
|
| Longitudinal Studies | 76 | 2024 | 14495 | 0.920 |
Why?
|
| Sex Hormone-Binding Globulin | 17 | 2023 | 546 | 0.910 |
Why?
|
| Cataract | 15 | 2016 | 827 | 0.900 |
Why?
|
| Prediabetic State | 4 | 2024 | 550 | 0.900 |
Why?
|
| Birth Weight | 16 | 2024 | 2097 | 0.900 |
Why?
|
| Blood Glucose | 37 | 2023 | 6381 | 0.900 |
Why?
|
| Metabolomics | 12 | 2024 | 1628 | 0.890 |
Why?
|
| Perimenopause | 4 | 2023 | 141 | 0.890 |
Why?
|
| Affect | 3 | 2021 | 1480 | 0.880 |
Why?
|
| Inflammation Mediators | 12 | 2020 | 1881 | 0.870 |
Why?
|
| Time Factors | 103 | 2024 | 40165 | 0.860 |
Why?
|
| Sex Factors | 51 | 2022 | 10547 | 0.860 |
Why?
|
| Administration, Cutaneous | 16 | 2023 | 713 | 0.860 |
Why?
|
| Air Pollution | 12 | 2023 | 2317 | 0.860 |
Why?
|
| Body Height | 11 | 2021 | 1570 | 0.860 |
Why?
|
| Candy | 2 | 2020 | 36 | 0.850 |
Why?
|
| Seafood | 8 | 2024 | 390 | 0.850 |
Why?
|
| Dietary Fiber | 24 | 2018 | 760 | 0.850 |
Why?
|
| Blood Pressure | 42 | 2024 | 8525 | 0.840 |
Why?
|
| Epidemiologic Studies | 10 | 2019 | 670 | 0.830 |
Why?
|
| Medroxyprogesterone | 3 | 2017 | 35 | 0.830 |
Why?
|
| Adiponectin | 16 | 2023 | 1115 | 0.820 |
Why?
|
| Pancreatic Neoplasms | 23 | 2023 | 5351 | 0.820 |
Why?
|
| Progesterone | 16 | 2023 | 742 | 0.820 |
Why?
|
| Health Surveys | 45 | 2021 | 4063 | 0.820 |
Why?
|
| Nutrition Policy | 11 | 2021 | 470 | 0.820 |
Why?
|
| Vitamin D-Binding Protein | 4 | 2018 | 131 | 0.820 |
Why?
|
| Gonadal Steroid Hormones | 14 | 2017 | 701 | 0.810 |
Why?
|
| Fish Oils | 6 | 2023 | 482 | 0.810 |
Why?
|
| Health Status | 27 | 2023 | 4081 | 0.810 |
Why?
|
| Dietary Proteins | 14 | 2022 | 949 | 0.800 |
Why?
|
| Evidence-Based Medicine | 11 | 2024 | 3696 | 0.800 |
Why?
|
| Diabetic Nephropathies | 5 | 2023 | 988 | 0.800 |
Why?
|
| Cholesterol, LDL | 21 | 2022 | 2420 | 0.790 |
Why?
|
| Salpingectomy | 3 | 2017 | 48 | 0.780 |
Why?
|
| DNA Methylation | 15 | 2024 | 4373 | 0.780 |
Why?
|
| Fatty Acids | 13 | 2023 | 1804 | 0.780 |
Why?
|
| Minerals | 5 | 2024 | 283 | 0.780 |
Why?
|
| Cerebrovascular Disorders | 25 | 2017 | 1501 | 0.780 |
Why?
|
| Atrial Fibrillation | 16 | 2023 | 5209 | 0.770 |
Why?
|
| Diet Surveys | 27 | 2021 | 1161 | 0.770 |
Why?
|
| Genetic Predisposition to Disease | 47 | 2024 | 17790 | 0.760 |
Why?
|
| Osteoporosis | 6 | 2023 | 1600 | 0.740 |
Why?
|
| Coffee | 12 | 2023 | 582 | 0.740 |
Why?
|
| Air Pollutants | 12 | 2023 | 2844 | 0.740 |
Why?
|
| Depressive Disorder | 5 | 2021 | 3726 | 0.740 |
Why?
|
| Decision Making | 8 | 2017 | 3925 | 0.730 |
Why?
|
| Cross-Sectional Studies | 90 | 2024 | 25942 | 0.730 |
Why?
|
| Brain Ischemia | 24 | 2020 | 3127 | 0.730 |
Why?
|
| Eating | 16 | 2023 | 1539 | 0.730 |
Why?
|
| Cognition Disorders | 23 | 2020 | 3976 | 0.730 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2023 | 269 | 0.730 |
Why?
|
| Nutrition Surveys | 14 | 2024 | 1725 | 0.720 |
Why?
|
| Placebos | 22 | 2021 | 1668 | 0.720 |
Why?
|
| Carotenoids | 20 | 2020 | 620 | 0.720 |
Why?
|
| Men's Health | 2 | 2020 | 70 | 0.720 |
Why?
|
| Counseling | 3 | 2019 | 1548 | 0.710 |
Why?
|
| Clinical Trials as Topic | 27 | 2022 | 8056 | 0.710 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 12 | 2017 | 2282 | 0.710 |
Why?
|
| Lipoproteins, HDL | 2 | 2024 | 667 | 0.710 |
Why?
|
| Epigenesis, Genetic | 16 | 2024 | 3758 | 0.700 |
Why?
|
| Diabetes Complications | 15 | 2019 | 1341 | 0.700 |
Why?
|
| Vagina | 5 | 2019 | 837 | 0.700 |
Why?
|
| Interleukin-6 | 24 | 2020 | 3215 | 0.700 |
Why?
|
| Multiple Organ Failure | 3 | 2018 | 386 | 0.690 |
Why?
|
| Menarche | 10 | 2024 | 529 | 0.690 |
Why?
|
| Anti-Mullerian Hormone | 6 | 2022 | 407 | 0.690 |
Why?
|
| Environmental Exposure | 21 | 2023 | 4412 | 0.680 |
Why?
|
| Treatment Outcome | 70 | 2024 | 65017 | 0.680 |
Why?
|
| Logistic Models | 67 | 2023 | 13314 | 0.670 |
Why?
|
| Insulin | 36 | 2023 | 6597 | 0.670 |
Why?
|
| Sickle Cell Trait | 4 | 2023 | 85 | 0.670 |
Why?
|
| Adipose Tissue | 12 | 2024 | 3301 | 0.670 |
Why?
|
| Lipids | 22 | 2024 | 3336 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 12 | 2019 | 7475 | 0.660 |
Why?
|
| Health Promotion | 12 | 2022 | 2206 | 0.650 |
Why?
|
| Pregnancy | 58 | 2024 | 29749 | 0.640 |
Why?
|
| Hyperlipidemias | 7 | 2019 | 782 | 0.640 |
Why?
|
| Trans Fatty Acids | 7 | 2023 | 155 | 0.640 |
Why?
|
| Caffeine | 11 | 2016 | 702 | 0.640 |
Why?
|
| Sarcopenia | 2 | 2022 | 372 | 0.640 |
Why?
|
| Absorptiometry, Photon | 10 | 2023 | 1736 | 0.630 |
Why?
|
| Heart Diseases | 9 | 2021 | 2809 | 0.630 |
Why?
|
| Venous Thromboembolism | 9 | 2023 | 1864 | 0.630 |
Why?
|
| Nuts | 7 | 2019 | 263 | 0.620 |
Why?
|
| Research Design | 20 | 2020 | 6180 | 0.610 |
Why?
|
| Nutritional Status | 13 | 2021 | 1607 | 0.610 |
Why?
|
| Sexual Dysfunction, Physiological | 5 | 2017 | 357 | 0.610 |
Why?
|
| Sodium, Dietary | 6 | 2024 | 425 | 0.610 |
Why?
|
| Drug Therapy, Combination | 20 | 2021 | 6498 | 0.610 |
Why?
|
| Quality of Life | 23 | 2023 | 13308 | 0.600 |
Why?
|
| Self Report | 26 | 2024 | 3711 | 0.600 |
Why?
|
| Autoimmune Diseases | 4 | 2024 | 2250 | 0.590 |
Why?
|
| Carotid Artery Diseases | 5 | 2020 | 883 | 0.590 |
Why?
|
| Genome-Wide Association Study | 30 | 2024 | 12626 | 0.590 |
Why?
|
| Sex Characteristics | 11 | 2022 | 2629 | 0.590 |
Why?
|
| Calcinosis | 7 | 2015 | 1476 | 0.580 |
Why?
|
| Diet, Vegetarian | 6 | 2022 | 180 | 0.580 |
Why?
|
| Pandemics | 9 | 2023 | 8624 | 0.570 |
Why?
|
| Premature Birth | 6 | 2024 | 1771 | 0.570 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2018 | 174 | 0.570 |
Why?
|
| Ovarian Neoplasms | 10 | 2023 | 4878 | 0.570 |
Why?
|
| Multiple Trauma | 2 | 2018 | 369 | 0.560 |
Why?
|
| Endothelium, Vascular | 14 | 2018 | 4433 | 0.560 |
Why?
|
| Osteoporosis, Postmenopausal | 8 | 2024 | 393 | 0.560 |
Why?
|
| Fatty Acids, Unsaturated | 9 | 2019 | 542 | 0.560 |
Why?
|
| Particulate Matter | 14 | 2023 | 2559 | 0.550 |
Why?
|
| Physicians | 42 | 2017 | 4591 | 0.550 |
Why?
|
| Adult Children | 1 | 2017 | 103 | 0.550 |
Why?
|
| Obesity, Abdominal | 6 | 2022 | 374 | 0.550 |
Why?
|
| Menstruation Disturbances | 4 | 2021 | 143 | 0.540 |
Why?
|
| Smoking Cessation | 11 | 2020 | 2064 | 0.540 |
Why?
|
| Hospitalization | 15 | 2024 | 10790 | 0.540 |
Why?
|
| Erythrocytes | 9 | 2022 | 2415 | 0.530 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2021 | 10827 | 0.530 |
Why?
|
| Meat | 10 | 2022 | 584 | 0.530 |
Why?
|
| Carcinoma, Ductal, Breast | 5 | 2022 | 1096 | 0.530 |
Why?
|
| Drug Combinations | 16 | 2018 | 2025 | 0.520 |
Why?
|
| Cholesterol | 25 | 2024 | 2924 | 0.520 |
Why?
|
| Triglycerides | 19 | 2023 | 2476 | 0.520 |
Why?
|
| Calcium Channel Blockers | 3 | 2017 | 694 | 0.520 |
Why?
|
| Cataract Extraction | 8 | 2016 | 465 | 0.510 |
Why?
|
| Antihypertensive Agents | 8 | 2024 | 2061 | 0.500 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2024 | 998 | 0.500 |
Why?
|
| Phthalic Acids | 4 | 2021 | 476 | 0.500 |
Why?
|
| Fishes | 8 | 2024 | 601 | 0.490 |
Why?
|
| Ovary | 4 | 2023 | 958 | 0.490 |
Why?
|
| Lymphocyte Subsets | 1 | 2016 | 310 | 0.490 |
Why?
|
| Diabetic Angiopathies | 8 | 2016 | 822 | 0.490 |
Why?
|
| Prevalence | 37 | 2023 | 15687 | 0.490 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 10 | 2019 | 346 | 0.480 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 4 | 2024 | 936 | 0.480 |
Why?
|
| Telomere | 8 | 2023 | 933 | 0.480 |
Why?
|
| Gender Identity | 1 | 2020 | 698 | 0.480 |
Why?
|
| Drug Compounding | 3 | 2021 | 246 | 0.480 |
Why?
|
| Treatment Failure | 6 | 2021 | 2648 | 0.480 |
Why?
|
| Beverages | 11 | 2024 | 820 | 0.480 |
Why?
|
| Intercellular Adhesion Molecule-1 | 13 | 2024 | 1126 | 0.470 |
Why?
|
| Linear Models | 32 | 2021 | 5877 | 0.470 |
Why?
|
| Cholesterol, Dietary | 5 | 2023 | 223 | 0.470 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2015 | 146 | 0.470 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2021 | 227 | 0.470 |
Why?
|
| Directive Counseling | 1 | 2015 | 171 | 0.470 |
Why?
|
| Resistance Training | 4 | 2020 | 185 | 0.460 |
Why?
|
| Body Fat Distribution | 5 | 2019 | 243 | 0.460 |
Why?
|
| Socioeconomic Factors | 24 | 2023 | 7806 | 0.460 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2023 | 518 | 0.460 |
Why?
|
| Dehydroepiandrosterone Sulfate | 6 | 2018 | 240 | 0.460 |
Why?
|
| Isoflavones | 3 | 2020 | 136 | 0.460 |
Why?
|
| Weight Loss | 15 | 2023 | 2686 | 0.460 |
Why?
|
| Pregnancy Complications | 4 | 2023 | 2942 | 0.450 |
Why?
|
| Diet Therapy | 3 | 2021 | 151 | 0.450 |
Why?
|
| Sleep | 14 | 2023 | 4751 | 0.450 |
Why?
|
| Product Labeling | 1 | 2014 | 77 | 0.450 |
Why?
|
| Phytosterols | 2 | 2023 | 55 | 0.450 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 2315 | 0.450 |
Why?
|
| Gene Frequency | 18 | 2024 | 3615 | 0.440 |
Why?
|
| Water | 5 | 2023 | 1407 | 0.440 |
Why?
|
| Contraceptives, Oral, Hormonal | 4 | 2018 | 190 | 0.440 |
Why?
|
| Lipoproteins | 6 | 2020 | 882 | 0.440 |
Why?
|
| Cardiovascular System | 1 | 2021 | 850 | 0.430 |
Why?
|
| Comorbidity | 30 | 2021 | 10551 | 0.430 |
Why?
|
| Prognosis | 48 | 2023 | 29658 | 0.430 |
Why?
|
| Biomedical Research | 4 | 2020 | 3426 | 0.420 |
Why?
|
| Fasting | 12 | 2022 | 1603 | 0.420 |
Why?
|
| Leptin | 6 | 2023 | 1591 | 0.420 |
Why?
|
| Radon | 2 | 2024 | 84 | 0.420 |
Why?
|
| Testosterone | 11 | 2020 | 2470 | 0.420 |
Why?
|
| Independent Living | 5 | 2022 | 570 | 0.420 |
Why?
|
| Breast | 5 | 2018 | 1963 | 0.420 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 8547 | 0.410 |
Why?
|
| Flavonols | 2 | 2016 | 83 | 0.410 |
Why?
|
| Body Constitution | 9 | 2004 | 273 | 0.410 |
Why?
|
| Leukocytes | 9 | 2023 | 2026 | 0.410 |
Why?
|
| Medical History Taking | 4 | 2015 | 773 | 0.410 |
Why?
|
| Diabetic Retinopathy | 6 | 2023 | 1268 | 0.410 |
Why?
|
| Antidepressive Agents | 8 | 2024 | 2890 | 0.410 |
Why?
|
| Hyperglycemia | 4 | 2017 | 1380 | 0.410 |
Why?
|
| Disease | 1 | 2017 | 671 | 0.400 |
Why?
|
| Secondary Prevention | 4 | 2018 | 1548 | 0.400 |
Why?
|
| Residence Characteristics | 7 | 2023 | 2062 | 0.400 |
Why?
|
| Glucose Intolerance | 7 | 2014 | 580 | 0.400 |
Why?
|
| E-Selectin | 8 | 2010 | 576 | 0.390 |
Why?
|
| Postpartum Period | 5 | 2024 | 1167 | 0.390 |
Why?
|
| Stroke Volume | 12 | 2024 | 5523 | 0.380 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2020 | 1463 | 0.380 |
Why?
|
| Models, Cardiovascular | 3 | 2016 | 978 | 0.380 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2012 | 186 | 0.380 |
Why?
|
| Administration, Oral | 16 | 2020 | 4035 | 0.380 |
Why?
|
| Premenopause | 14 | 2022 | 1038 | 0.380 |
Why?
|
| Hypoglycemic Agents | 7 | 2020 | 3150 | 0.380 |
Why?
|
| Sexual Behavior | 8 | 2018 | 2086 | 0.380 |
Why?
|
| Tamoxifen | 2 | 2015 | 963 | 0.370 |
Why?
|
| Dysmenorrhea | 1 | 2012 | 98 | 0.370 |
Why?
|
| Apolipoprotein E4 | 4 | 2024 | 707 | 0.370 |
Why?
|
| Clinical Competence | 3 | 2017 | 4783 | 0.370 |
Why?
|
| Tunica Media | 1 | 2011 | 112 | 0.370 |
Why?
|
| Prostaglandins | 1 | 2012 | 398 | 0.370 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 8 | 2019 | 1079 | 0.370 |
Why?
|
| Myocardial Revascularization | 6 | 2022 | 841 | 0.370 |
Why?
|
| Carotid Arteries | 2 | 2015 | 951 | 0.360 |
Why?
|
| Pyridoxine | 3 | 2009 | 108 | 0.360 |
Why?
|
| Calcifediol | 5 | 2018 | 161 | 0.360 |
Why?
|
| Soy Foods | 2 | 2024 | 44 | 0.360 |
Why?
|
| Polymorphism, Genetic | 13 | 2012 | 4291 | 0.360 |
Why?
|
| Phosphatidylcholines | 3 | 2018 | 406 | 0.360 |
Why?
|
| Confidence Intervals | 29 | 2021 | 2932 | 0.360 |
Why?
|
| Pregnancy Outcome | 8 | 2023 | 2907 | 0.360 |
Why?
|
| Diabetic Neuropathies | 3 | 2023 | 406 | 0.360 |
Why?
|
| Disease Progression | 19 | 2024 | 13502 | 0.360 |
Why?
|
| Social Support | 7 | 2023 | 2145 | 0.350 |
Why?
|
| Cyclohexanols | 3 | 2015 | 126 | 0.350 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2017 | 94 | 0.340 |
Why?
|
| Genetic Variation | 13 | 2024 | 6551 | 0.340 |
Why?
|
| Tea | 7 | 2023 | 284 | 0.340 |
Why?
|
| Glomerular Filtration Rate | 5 | 2024 | 2180 | 0.340 |
Why?
|
| Receptors, Estrogen | 12 | 2020 | 2210 | 0.340 |
Why?
|
| Melatonin | 3 | 2024 | 668 | 0.340 |
Why?
|
| Resistin | 4 | 2016 | 172 | 0.340 |
Why?
|
| Glycemic Index | 8 | 2017 | 396 | 0.340 |
Why?
|
| Myocardial Ischemia | 8 | 2023 | 2164 | 0.330 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 3388 | 0.330 |
Why?
|
| Proinsulin | 3 | 2013 | 135 | 0.330 |
Why?
|
| Intention to Treat Analysis | 2 | 2020 | 422 | 0.330 |
Why?
|
| Life Expectancy | 4 | 2024 | 1248 | 0.330 |
Why?
|
| Noise, Transportation | 2 | 2022 | 51 | 0.330 |
Why?
|
| Carcinoma, Lobular | 1 | 2013 | 489 | 0.330 |
Why?
|
| Abdominal Fat | 4 | 2024 | 223 | 0.320 |
Why?
|
| Tunica Intima | 1 | 2011 | 459 | 0.320 |
Why?
|
| Health Policy | 1 | 2021 | 2677 | 0.320 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2022 | 2496 | 0.320 |
Why?
|
| Adenoma | 5 | 2022 | 2148 | 0.310 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 830 | 0.310 |
Why?
|
| Exercise Therapy | 4 | 2024 | 919 | 0.310 |
Why?
|
| DNA | 3 | 2021 | 7233 | 0.310 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2015 | 812 | 0.310 |
Why?
|
| Regression Analysis | 24 | 2019 | 6360 | 0.310 |
Why?
|
| Epigenomics | 3 | 2023 | 936 | 0.310 |
Why?
|
| Environmental Pollutants | 4 | 2023 | 1266 | 0.310 |
Why?
|
| Pharmaceutical Preparations | 1 | 2016 | 1091 | 0.310 |
Why?
|
| Dietary Sucrose | 5 | 2017 | 244 | 0.310 |
Why?
|
| Mammography | 9 | 2024 | 2427 | 0.310 |
Why?
|
| Diet Records | 12 | 2022 | 427 | 0.310 |
Why?
|
| Hyperinsulinism | 4 | 2020 | 402 | 0.300 |
Why?
|
| Health Expenditures | 2 | 2020 | 2362 | 0.300 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2021 | 516 | 0.300 |
Why?
|
| Androgens | 6 | 2024 | 1291 | 0.300 |
Why?
|
| Death Certificates | 3 | 2010 | 167 | 0.300 |
Why?
|
| Appetite Depressants | 3 | 1997 | 108 | 0.300 |
Why?
|
| Urinary Incontinence | 2 | 2022 | 495 | 0.290 |
Why?
|
| Hypercholesterolemia | 16 | 2017 | 1155 | 0.290 |
Why?
|
| Plant Extracts | 5 | 2023 | 496 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 7 | 2023 | 3763 | 0.290 |
Why?
|
| Memory Disorders | 5 | 2020 | 1197 | 0.290 |
Why?
|
| DNA, Mitochondrial | 4 | 2021 | 858 | 0.290 |
Why?
|
| Patient Selection | 5 | 2016 | 4283 | 0.290 |
Why?
|
| Thyroid Diseases | 2 | 2021 | 386 | 0.290 |
Why?
|
| 25-Hydroxyvitamin D 2 | 4 | 2018 | 40 | 0.290 |
Why?
|
| Geriatric Assessment | 5 | 2020 | 1405 | 0.290 |
Why?
|
| Flavones | 1 | 2007 | 68 | 0.280 |
Why?
|
| Behavior | 2 | 2008 | 540 | 0.280 |
Why?
|
| Predictive Value of Tests | 31 | 2024 | 15289 | 0.280 |
Why?
|
| Drug Administration Schedule | 12 | 2017 | 4899 | 0.280 |
Why?
|
| Wounds and Injuries | 6 | 2017 | 2477 | 0.280 |
Why?
|
| Physician's Role | 1 | 2014 | 918 | 0.280 |
Why?
|
| Progesterone Congeners | 2 | 2003 | 44 | 0.280 |
Why?
|
| Food Preferences | 4 | 2020 | 399 | 0.280 |
Why?
|
| Physical Exertion | 3 | 2011 | 662 | 0.280 |
Why?
|
| Migraine Disorders | 6 | 2023 | 1693 | 0.280 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2004 | 854 | 0.280 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 1416 | 0.280 |
Why?
|
| Nutritional Requirements | 4 | 2012 | 275 | 0.280 |
Why?
|
| Educational Status | 7 | 2023 | 2515 | 0.270 |
Why?
|
| Linkage Disequilibrium | 8 | 2024 | 1996 | 0.270 |
Why?
|
| Dietary Fats, Unsaturated | 5 | 2017 | 225 | 0.270 |
Why?
|
| Selenium | 4 | 2020 | 416 | 0.270 |
Why?
|
| Atrophy | 4 | 2019 | 1627 | 0.270 |
Why?
|
| Receptors, Leptin | 3 | 2023 | 350 | 0.270 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2167 | 0.270 |
Why?
|
| American Heart Association | 5 | 2021 | 1081 | 0.270 |
Why?
|
| Aromatase Inhibitors | 2 | 2015 | 511 | 0.270 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2290 | 0.270 |
Why?
|
| Colonic Polyps | 4 | 2020 | 551 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 4 | 2011 | 1602 | 0.260 |
Why?
|
| Thromboembolism | 3 | 2011 | 1017 | 0.260 |
Why?
|
| Physical Fitness | 6 | 2020 | 732 | 0.260 |
Why?
|
| Shock, Hemorrhagic | 2 | 2018 | 223 | 0.260 |
Why?
|
| Ethanol | 6 | 2021 | 1323 | 0.260 |
Why?
|
| Drug Administration Routes | 2 | 2021 | 150 | 0.260 |
Why?
|
| Energy Metabolism | 9 | 2024 | 2869 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 12 | 2013 | 3455 | 0.260 |
Why?
|
| Personality | 2 | 2019 | 552 | 0.250 |
Why?
|
| Meta-Analysis as Topic | 6 | 2021 | 1376 | 0.250 |
Why?
|
| Pets | 2 | 2016 | 47 | 0.250 |
Why?
|
| Nutrition Assessment | 14 | 2019 | 727 | 0.250 |
Why?
|
| Survival Rate | 16 | 2020 | 12808 | 0.250 |
Why?
|
| Hemodynamics | 2 | 2014 | 4174 | 0.250 |
Why?
|
| Estrone | 5 | 2022 | 232 | 0.250 |
Why?
|
| Health Personnel | 13 | 2019 | 3310 | 0.250 |
Why?
|
| Medication Adherence | 2 | 2019 | 2165 | 0.240 |
Why?
|
| Abortion, Spontaneous | 2 | 2021 | 530 | 0.240 |
Why?
|
| Body Weights and Measures | 2 | 2017 | 208 | 0.240 |
Why?
|
| Lung Neoplasms | 10 | 2024 | 13262 | 0.240 |
Why?
|
| Finland | 3 | 2023 | 603 | 0.240 |
Why?
|
| Survival Analysis | 15 | 2024 | 10182 | 0.240 |
Why?
|
| Hemostasis | 5 | 2011 | 468 | 0.240 |
Why?
|
| Micronutrients | 4 | 2021 | 381 | 0.240 |
Why?
|
| Gallstones | 2 | 2018 | 283 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 4 | 2023 | 2696 | 0.240 |
Why?
|
| Forecasting | 3 | 2019 | 2932 | 0.240 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2138 | 0.240 |
Why?
|
| Hostility | 2 | 2019 | 183 | 0.240 |
Why?
|
| Lipoprotein(a) | 5 | 2020 | 499 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2016 | 3224 | 0.240 |
Why?
|
| Meglutol | 1 | 2024 | 5 | 0.240 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2012 | 1928 | 0.240 |
Why?
|
| Activated Protein C Resistance | 2 | 2015 | 18 | 0.240 |
Why?
|
| Coronary Angiography | 6 | 2017 | 4563 | 0.230 |
Why?
|
| Reference Values | 12 | 2020 | 4925 | 0.230 |
Why?
|
| Pulmonary Embolism | 8 | 2021 | 2543 | 0.230 |
Why?
|
| Maternal Age | 6 | 2019 | 807 | 0.230 |
Why?
|
| Erythritol | 1 | 2023 | 3 | 0.230 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2020 | 1717 | 0.230 |
Why?
|
| Algorithms | 8 | 2024 | 13981 | 0.230 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2015 | 3529 | 0.230 |
Why?
|
| Exercise Test | 3 | 2020 | 2128 | 0.230 |
Why?
|
| Heme | 2 | 2024 | 313 | 0.230 |
Why?
|
| Disease Susceptibility | 4 | 2019 | 1791 | 0.230 |
Why?
|
| Coronary Vessels | 7 | 2022 | 3112 | 0.230 |
Why?
|
| Methylamines | 3 | 2020 | 138 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 8 | 2013 | 691 | 0.230 |
Why?
|
| Ovulation | 2 | 2002 | 181 | 0.220 |
Why?
|
| Citalopram | 2 | 2018 | 402 | 0.220 |
Why?
|
| Genotype | 23 | 2024 | 12960 | 0.220 |
Why?
|
| Metabolome | 5 | 2024 | 982 | 0.220 |
Why?
|
| Femur Neck | 3 | 2021 | 312 | 0.220 |
Why?
|
| Mass Screening | 5 | 2022 | 5423 | 0.220 |
Why?
|
| Models, Statistical | 7 | 2020 | 5075 | 0.220 |
Why?
|
| Glucose | 7 | 2023 | 4351 | 0.220 |
Why?
|
| Kidney Calculi | 3 | 2019 | 468 | 0.220 |
Why?
|
| Apolipoproteins E | 5 | 2024 | 1436 | 0.220 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2024 | 6544 | 0.220 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3763 | 0.220 |
Why?
|
| Hemorrhage | 5 | 2020 | 3600 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7408 | 0.220 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2022 | 725 | 0.220 |
Why?
|
| Metformin | 3 | 2017 | 912 | 0.210 |
Why?
|
| Leukocyte Count | 4 | 2024 | 1600 | 0.210 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2008 | 415 | 0.210 |
Why?
|
| Mood Disorders | 4 | 2015 | 1124 | 0.210 |
Why?
|
| Magnesium Deficiency | 2 | 2020 | 48 | 0.210 |
Why?
|
| Loneliness | 2 | 2022 | 197 | 0.210 |
Why?
|
| Pericardium | 3 | 2019 | 675 | 0.210 |
Why?
|
| Systole | 8 | 2024 | 947 | 0.210 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 2013 | 0.210 |
Why?
|
| Reproducibility of Results | 29 | 2024 | 20080 | 0.210 |
Why?
|
| Models, Biological | 5 | 2018 | 9467 | 0.210 |
Why?
|
| Hypothalamic Diseases | 1 | 2023 | 134 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5325 | 0.210 |
Why?
|
| Observation | 5 | 2008 | 312 | 0.210 |
Why?
|
| Women | 5 | 2018 | 225 | 0.210 |
Why?
|
| Memory | 7 | 2024 | 2179 | 0.200 |
Why?
|
| Diet, Carbohydrate-Restricted | 3 | 2023 | 261 | 0.200 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2021 | 363 | 0.200 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2006 | 618 | 0.200 |
Why?
|
| Postnatal Care | 2 | 2015 | 260 | 0.200 |
Why?
|
| Chi-Square Distribution | 13 | 2017 | 3465 | 0.200 |
Why?
|
| Women, Working | 2 | 2005 | 86 | 0.200 |
Why?
|
| Potassium, Dietary | 2 | 2024 | 104 | 0.200 |
Why?
|
| Nitrogen Dioxide | 5 | 2023 | 512 | 0.200 |
Why?
|
| Persea | 1 | 2022 | 18 | 0.200 |
Why?
|
| Starvation | 1 | 2022 | 140 | 0.200 |
Why?
|
| Hyperhomocysteinemia | 2 | 2021 | 118 | 0.200 |
Why?
|
| Paroxetine | 1 | 2023 | 182 | 0.200 |
Why?
|
| Receptors, Calcitriol | 5 | 2023 | 359 | 0.200 |
Why?
|
| Fractures, Spontaneous | 2 | 2017 | 231 | 0.200 |
Why?
|
| Population Surveillance | 8 | 2016 | 2608 | 0.200 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 88 | 0.200 |
Why?
|
| Conflict of Interest | 2 | 1997 | 549 | 0.200 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 42 | 0.200 |
Why?
|
| Sunlight | 3 | 2020 | 337 | 0.190 |
Why?
|
| Potassium | 5 | 2024 | 1313 | 0.190 |
Why?
|
| Alcoholic Beverages | 3 | 2021 | 264 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2023 | 3387 | 0.190 |
Why?
|
| Genome, Mitochondrial | 1 | 2021 | 66 | 0.190 |
Why?
|
| Anticarcinogenic Agents | 2 | 2014 | 249 | 0.190 |
Why?
|
| Iron | 5 | 2024 | 1786 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2018 | 257 | 0.190 |
Why?
|
| Epidemiologic Methods | 7 | 2017 | 1343 | 0.190 |
Why?
|
| DNA Glycosylases | 1 | 2022 | 124 | 0.190 |
Why?
|
| Leukoaraiosis | 1 | 2022 | 116 | 0.190 |
Why?
|
| Posture | 2 | 2017 | 953 | 0.190 |
Why?
|
| Cost of Illness | 5 | 2024 | 1940 | 0.190 |
Why?
|
| Hand Strength | 1 | 2024 | 452 | 0.190 |
Why?
|
| Young Adult | 31 | 2024 | 58741 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2019 | 1131 | 0.190 |
Why?
|
| Survival | 2 | 2020 | 161 | 0.190 |
Why?
|
| Mosaicism | 1 | 2024 | 466 | 0.190 |
Why?
|
| Pain | 6 | 2023 | 5066 | 0.190 |
Why?
|
| Women's Rights | 1 | 2021 | 65 | 0.180 |
Why?
|
| Common Cold | 1 | 2001 | 63 | 0.180 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2018 | 276 | 0.180 |
Why?
|
| Lignans | 1 | 2021 | 84 | 0.180 |
Why?
|
| Cysteine | 4 | 2014 | 895 | 0.180 |
Why?
|
| Massachusetts | 16 | 2024 | 8803 | 0.180 |
Why?
|
| Bundle-Branch Block | 2 | 2013 | 281 | 0.180 |
Why?
|
| Television | 2 | 2003 | 409 | 0.180 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2022 | 114 | 0.180 |
Why?
|
| Melanoma | 6 | 2018 | 5697 | 0.180 |
Why?
|
| Guideline Adherence | 3 | 2021 | 2283 | 0.180 |
Why?
|
| Rest | 3 | 2011 | 914 | 0.180 |
Why?
|
| Periodicity | 1 | 2002 | 348 | 0.180 |
Why?
|
| Proteins | 6 | 2021 | 6029 | 0.180 |
Why?
|
| Hormones | 6 | 2023 | 867 | 0.180 |
Why?
|
| Neuropsychological Tests | 9 | 2024 | 7021 | 0.180 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2012 | 226 | 0.180 |
Why?
|
| Apolipoprotein A-I | 3 | 2020 | 297 | 0.180 |
Why?
|
| Environment Design | 2 | 2013 | 172 | 0.180 |
Why?
|
| Heterozygote | 7 | 2024 | 2798 | 0.180 |
Why?
|
| Preventive Health Services | 2 | 2016 | 570 | 0.180 |
Why?
|
| Republic of Korea | 2 | 2020 | 566 | 0.180 |
Why?
|
| Genetic Markers | 3 | 2023 | 2608 | 0.180 |
Why?
|
| Disability Evaluation | 3 | 2016 | 1826 | 0.180 |
Why?
|
| Adenocarcinoma | 5 | 2017 | 6315 | 0.180 |
Why?
|
| Orgasm | 2 | 2017 | 61 | 0.180 |
Why?
|
| Histamine | 1 | 2022 | 498 | 0.180 |
Why?
|
| Adolescent | 42 | 2022 | 87810 | 0.170 |
Why?
|
| Venous Thrombosis | 3 | 2016 | 1299 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2018 | 4357 | 0.170 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2000 | 52 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 1652 | 0.170 |
Why?
|
| Fenfluramine | 2 | 1996 | 58 | 0.170 |
Why?
|
| Margarine | 2 | 2017 | 17 | 0.170 |
Why?
|
| Age Distribution | 15 | 2017 | 2893 | 0.170 |
Why?
|
| Bradycardia | 1 | 2021 | 299 | 0.170 |
Why?
|
| Vascular Diseases | 4 | 2013 | 1182 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 377 | 0.170 |
Why?
|
| Saliva | 1 | 2024 | 820 | 0.170 |
Why?
|
| Imidazolidines | 1 | 1999 | 38 | 0.170 |
Why?
|
| Ideal Body Weight | 1 | 2019 | 27 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 386 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2011 | 2313 | 0.170 |
Why?
|
| London | 2 | 2017 | 234 | 0.170 |
Why?
|
| Subcutaneous Fat | 1 | 2023 | 393 | 0.170 |
Why?
|
| Gallbladder Diseases | 1 | 2020 | 137 | 0.170 |
Why?
|
| Prenatal Care | 3 | 2015 | 1129 | 0.170 |
Why?
|
| Tocopherols | 1 | 2019 | 44 | 0.170 |
Why?
|
| Glutamine | 2 | 2023 | 576 | 0.170 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 457 | 0.160 |
Why?
|
| Yoga | 4 | 2018 | 281 | 0.160 |
Why?
|
| Europe | 5 | 2021 | 3441 | 0.160 |
Why?
|
| Paternal Age | 1 | 2019 | 87 | 0.160 |
Why?
|
| Hydroxycholesterols | 2 | 2024 | 25 | 0.160 |
Why?
|
| Thinness | 2 | 2017 | 491 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3986 | 0.160 |
Why?
|
| Food | 2 | 2020 | 771 | 0.160 |
Why?
|
| Genetic Loci | 7 | 2017 | 2618 | 0.160 |
Why?
|
| Career Choice | 2 | 2004 | 754 | 0.160 |
Why?
|
| Psoriasis | 2 | 2021 | 940 | 0.160 |
Why?
|
| Hematopoiesis | 3 | 2023 | 2050 | 0.160 |
Why?
|
| Homeostasis | 3 | 2023 | 3306 | 0.160 |
Why?
|
| Social Isolation | 1 | 2022 | 362 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 317 | 0.160 |
Why?
|
| Animals | 39 | 2024 | 167963 | 0.160 |
Why?
|
| Plants | 1 | 2020 | 317 | 0.160 |
Why?
|
| Biological Availability | 3 | 2018 | 395 | 0.160 |
Why?
|
| Fertility | 3 | 2021 | 773 | 0.160 |
Why?
|
| Vasectomy | 1 | 1999 | 51 | 0.160 |
Why?
|
| Pesticide Residues | 1 | 2019 | 95 | 0.160 |
Why?
|
| Skin Neoplasms | 5 | 2018 | 5799 | 0.160 |
Why?
|
| Proteome | 3 | 2024 | 1855 | 0.160 |
Why?
|
| Severity of Illness Index | 12 | 2020 | 15840 | 0.160 |
Why?
|
| Diabetic Foot | 1 | 2023 | 381 | 0.160 |
Why?
|
| Contraception | 2 | 2021 | 349 | 0.160 |
Why?
|
| Nitriles | 1 | 2004 | 956 | 0.160 |
Why?
|
| Guidelines as Topic | 4 | 2014 | 1392 | 0.160 |
Why?
|
| Iron, Dietary | 2 | 2024 | 148 | 0.160 |
Why?
|
| Adipokines | 2 | 2023 | 311 | 0.150 |
Why?
|
| Retrospective Studies | 31 | 2024 | 80372 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2714 | 0.150 |
Why?
|
| Triazoles | 1 | 2004 | 904 | 0.150 |
Why?
|
| Nails | 2 | 2012 | 295 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2021 | 1575 | 0.150 |
Why?
|
| Food Contamination | 1 | 2019 | 192 | 0.150 |
Why?
|
| Fast Foods | 3 | 2023 | 210 | 0.150 |
Why?
|
| Genetics, Population | 3 | 2017 | 930 | 0.150 |
Why?
|
| Chromatography, Liquid | 5 | 2020 | 987 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 542 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 105 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4319 | 0.150 |
Why?
|
| Societies, Medical | 6 | 2015 | 3905 | 0.150 |
Why?
|
| Apolipoprotein C-I | 1 | 2017 | 13 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2014 | 4897 | 0.150 |
Why?
|
| Endocrine Disruptors | 1 | 2021 | 263 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2002 | 539 | 0.150 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 1764 | 0.150 |
Why?
|
| Apolipoproteins B | 4 | 2014 | 388 | 0.150 |
Why?
|
| Sodium | 4 | 2024 | 1594 | 0.150 |
Why?
|
| Internal Medicine | 2 | 2016 | 1048 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2020 | 412 | 0.150 |
Why?
|
| Pre-Eclampsia | 3 | 2022 | 1229 | 0.150 |
Why?
|
| Dry Eye Syndromes | 1 | 2022 | 385 | 0.150 |
Why?
|
| Nitrates | 1 | 2019 | 264 | 0.150 |
Why?
|
| Killer Cells, Natural | 2 | 2017 | 2203 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 820 | 0.140 |
Why?
|
| Acceleration | 3 | 2023 | 189 | 0.140 |
Why?
|
| Medicare | 5 | 2022 | 6786 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 3 | 2017 | 190 | 0.140 |
Why?
|
| Butter | 1 | 2017 | 22 | 0.140 |
Why?
|
| Internship and Residency | 2 | 2016 | 5870 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2024 | 817 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2008 | 125 | 0.140 |
Why?
|
| CpG Islands | 4 | 2023 | 1221 | 0.140 |
Why?
|
| Carcinosarcoma | 1 | 2018 | 104 | 0.140 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2017 | 84 | 0.140 |
Why?
|
| Lactation | 3 | 2012 | 397 | 0.140 |
Why?
|
| Consultants | 1 | 1997 | 53 | 0.140 |
Why?
|
| alpha-Tocopherol | 4 | 2020 | 126 | 0.140 |
Why?
|
| Patient Compliance | 7 | 2024 | 2688 | 0.140 |
Why?
|
| Stress, Psychological | 5 | 2020 | 4446 | 0.140 |
Why?
|
| Age of Onset | 6 | 2018 | 3301 | 0.140 |
Why?
|
| Interviews as Topic | 3 | 2022 | 2659 | 0.140 |
Why?
|
| Health Status Indicators | 4 | 2016 | 968 | 0.140 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2017 | 59 | 0.140 |
Why?
|
| Spinal Fractures | 3 | 2014 | 702 | 0.140 |
Why?
|
| Glutamic Acid | 2 | 2023 | 1167 | 0.140 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 1064 | 0.140 |
Why?
|
| Pituitary Gland | 1 | 2019 | 637 | 0.140 |
Why?
|
| Chemoprevention | 3 | 2016 | 326 | 0.140 |
Why?
|
| Drinking | 3 | 2015 | 199 | 0.140 |
Why?
|
| Coffea | 1 | 2016 | 22 | 0.140 |
Why?
|
| Puerto Rico | 4 | 2024 | 373 | 0.140 |
Why?
|
| Activities of Daily Living | 6 | 2023 | 2417 | 0.140 |
Why?
|
| Ownership | 2 | 2016 | 339 | 0.140 |
Why?
|
| Avitaminosis | 1 | 2016 | 35 | 0.130 |
Why?
|
| History, 20th Century | 2 | 2021 | 2773 | 0.130 |
Why?
|
| Hypotension | 1 | 2022 | 883 | 0.130 |
Why?
|
| Research | 2 | 2017 | 1974 | 0.130 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2018 | 217 | 0.130 |
Why?
|
| Income | 3 | 2023 | 1875 | 0.130 |
Why?
|
| Albuminuria | 2 | 2018 | 659 | 0.130 |
Why?
|
| Angina Pectoris | 5 | 1997 | 969 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
| Personal Satisfaction | 3 | 2016 | 643 | 0.130 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1997 | 116 | 0.130 |
Why?
|
| Antigens, Ly | 1 | 2017 | 292 | 0.130 |
Why?
|
| Peptide Fragments | 3 | 2020 | 5125 | 0.130 |
Why?
|
| Dyslipidemias | 2 | 2021 | 895 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 37 | 0.130 |
Why?
|
| Incretins | 1 | 2017 | 103 | 0.130 |
Why?
|
| Seasons | 3 | 2019 | 1522 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2024 | 2101 | 0.130 |
Why?
|
| State Medicine | 1 | 2017 | 213 | 0.130 |
Why?
|
| Electrocardiography | 6 | 2023 | 6414 | 0.130 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 1902 | 0.130 |
Why?
|
| C-Peptide | 4 | 2020 | 433 | 0.130 |
Why?
|
| Faculty, Medical | 2 | 2017 | 1192 | 0.130 |
Why?
|
| Physicians, Women | 1 | 2002 | 495 | 0.130 |
Why?
|
| Fathers | 1 | 2018 | 376 | 0.130 |
Why?
|
| Sex Distribution | 9 | 2010 | 2295 | 0.130 |
Why?
|
| Irritable Mood | 1 | 2017 | 194 | 0.130 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 194 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 9 | 2018 | 3618 | 0.130 |
Why?
|
| Catechin | 1 | 2015 | 69 | 0.130 |
Why?
|
| Placebo Effect | 1 | 2019 | 520 | 0.130 |
Why?
|
| Phospholipids | 1 | 2019 | 789 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 3726 | 0.130 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4744 | 0.130 |
Why?
|
| Mental Health | 6 | 2022 | 3213 | 0.130 |
Why?
|
| Poultry | 2 | 2022 | 81 | 0.130 |
Why?
|
| Alopecia | 1 | 2000 | 414 | 0.130 |
Why?
|
| Repressor Proteins | 3 | 2021 | 2981 | 0.130 |
Why?
|
| Ultraviolet Rays | 2 | 2016 | 1078 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2019 | 6015 | 0.120 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1035 | 0.120 |
Why?
|
| Recurrence | 5 | 2022 | 8482 | 0.120 |
Why?
|
| Aspartate Aminotransferases | 2 | 2017 | 416 | 0.120 |
Why?
|
| Quercetin | 1 | 2015 | 97 | 0.120 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2018 | 303 | 0.120 |
Why?
|
| Netherlands | 1 | 2020 | 2213 | 0.120 |
Why?
|
| Horses | 3 | 2022 | 298 | 0.120 |
Why?
|
| Aromatase | 2 | 2012 | 147 | 0.120 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 219 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2015 | 20509 | 0.120 |
Why?
|
| Proteomics | 3 | 2024 | 3817 | 0.120 |
Why?
|
| Diet, Reducing | 3 | 2015 | 488 | 0.120 |
Why?
|
| Cadmium | 1 | 2016 | 215 | 0.120 |
Why?
|
| Interpersonal Relations | 2 | 2020 | 1428 | 0.120 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2015 | 267 | 0.120 |
Why?
|
| Carbonated Beverages | 5 | 2023 | 209 | 0.120 |
Why?
|
| Dioxygenases | 3 | 2021 | 335 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2024 | 2566 | 0.120 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2018 | 489 | 0.120 |
Why?
|
| Child Abuse | 1 | 2023 | 1067 | 0.120 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2014 | 60 | 0.120 |
Why?
|
| Social Conformity | 1 | 1994 | 39 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2016 | 580 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2015 | 129 | 0.120 |
Why?
|
| Nevus, Pigmented | 1 | 2016 | 221 | 0.120 |
Why?
|
| Anovulation | 1 | 1994 | 54 | 0.120 |
Why?
|
| Ventricular Function, Left | 3 | 2024 | 3880 | 0.120 |
Why?
|
| Fetal Macrosomia | 1 | 2015 | 131 | 0.120 |
Why?
|
| Acute-Phase Proteins | 2 | 2016 | 250 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 239 | 0.120 |
Why?
|
| Amino Acids | 1 | 2020 | 1714 | 0.120 |
Why?
|
| Platelet Count | 1 | 2017 | 777 | 0.120 |
Why?
|
| Transcription Factors | 6 | 2017 | 12103 | 0.120 |
Why?
|
| Alleles | 9 | 2023 | 6898 | 0.120 |
Why?
|
| Microsatellite Instability | 2 | 2015 | 715 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 249 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 3 | 2024 | 608 | 0.110 |
Why?
|
| Receptors, Progesterone | 7 | 2020 | 1130 | 0.110 |
Why?
|
| Statistics, Nonparametric | 9 | 2021 | 2852 | 0.110 |
Why?
|
| Population Groups | 2 | 2012 | 211 | 0.110 |
Why?
|
| Alanine Transaminase | 2 | 2017 | 606 | 0.110 |
Why?
|
| Oxidative Stress | 9 | 2020 | 3106 | 0.110 |
Why?
|
| Bone Remodeling | 1 | 2017 | 580 | 0.110 |
Why?
|
| Mobility Limitation | 1 | 2018 | 402 | 0.110 |
Why?
|
| Meat Products | 2 | 2004 | 96 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2018 | 788 | 0.110 |
Why?
|
| Probability | 8 | 2010 | 2475 | 0.110 |
Why?
|
| Lymphoma, Follicular | 1 | 2018 | 453 | 0.110 |
Why?
|
| Naproxen | 1 | 2014 | 100 | 0.110 |
Why?
|
| BRCA1 Protein | 2 | 2017 | 1147 | 0.110 |
Why?
|
| Time | 3 | 2020 | 545 | 0.110 |
Why?
|
| Drinking Behavior | 1 | 2014 | 103 | 0.110 |
Why?
|
| Hemoglobins | 2 | 2018 | 1521 | 0.110 |
Why?
|
| Heart Rate | 4 | 2022 | 4179 | 0.110 |
Why?
|
| Abdomen | 5 | 2007 | 1130 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1084 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2019 | 1195 | 0.110 |
Why?
|
| Muscles | 3 | 2023 | 1581 | 0.110 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2013 | 30 | 0.110 |
Why?
|
| Pituitary Neoplasms | 1 | 2022 | 1313 | 0.110 |
Why?
|
| Food Handling | 3 | 2011 | 155 | 0.110 |
Why?
|
| Dogs | 2 | 2016 | 3841 | 0.110 |
Why?
|
| Minority Groups | 1 | 2020 | 1201 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1456 | 0.110 |
Why?
|
| Prescriptions | 1 | 2015 | 388 | 0.110 |
Why?
|
| Mutation | 7 | 2023 | 29932 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 2 | 2013 | 907 | 0.110 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 306 | 0.110 |
Why?
|
| Wrist Injuries | 1 | 2015 | 214 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2017 | 720 | 0.110 |
Why?
|
| North America | 1 | 2016 | 1284 | 0.110 |
Why?
|
| Dehydroepiandrosterone | 3 | 2008 | 257 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2017 | 1223 | 0.110 |
Why?
|
| Calibration | 3 | 2022 | 816 | 0.110 |
Why?
|
| Pyridoxal Phosphate | 2 | 2010 | 124 | 0.110 |
Why?
|
| Apolipoprotein B-100 | 4 | 2020 | 155 | 0.100 |
Why?
|
| Domestic Violence | 1 | 2014 | 181 | 0.100 |
Why?
|
| Juglans | 1 | 2013 | 45 | 0.100 |
Why?
|
| Heart Conduction System | 3 | 2013 | 1015 | 0.100 |
Why?
|
| Endocrine System | 1 | 2013 | 112 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2014 | 229 | 0.100 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 464 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2020 | 780 | 0.100 |
Why?
|
| Interferons | 1 | 2016 | 705 | 0.100 |
Why?
|
| Prolactin | 5 | 1999 | 621 | 0.100 |
Why?
|
| Metagenomics | 2 | 2013 | 457 | 0.100 |
Why?
|
| Statistics as Topic | 6 | 2017 | 2362 | 0.100 |
Why?
|
| Gait | 1 | 2018 | 812 | 0.100 |
Why?
|
| alpha-Linolenic Acid | 2 | 2005 | 144 | 0.100 |
Why?
|
| Phospholipases A2 | 1 | 2012 | 197 | 0.100 |
Why?
|
| Immunity | 2 | 2020 | 998 | 0.100 |
Why?
|
| Glaucoma | 1 | 2022 | 1182 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 1952 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 697 | 0.100 |
Why?
|
| Climacteric | 1 | 2012 | 57 | 0.100 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 718 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1386 | 0.100 |
Why?
|
| Blood Coagulation | 3 | 2013 | 1157 | 0.100 |
Why?
|
| Phenotype | 10 | 2024 | 16546 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 4490 | 0.100 |
Why?
|
| Knee Joint | 1 | 2020 | 1663 | 0.100 |
Why?
|
| Genetic Association Studies | 7 | 2015 | 2717 | 0.100 |
Why?
|
| Diastole | 4 | 2018 | 788 | 0.100 |
Why?
|
| Editorial Policies | 1 | 1996 | 457 | 0.100 |
Why?
|
| Research Report | 1 | 2015 | 370 | 0.100 |
Why?
|
| Biological Products | 1 | 2021 | 916 | 0.100 |
Why?
|
| Colitis, Ulcerative | 2 | 2015 | 1919 | 0.100 |
Why?
|
| Self Disclosure | 3 | 2000 | 249 | 0.100 |
Why?
|
| Lipoproteins, LDL | 3 | 2020 | 641 | 0.100 |
Why?
|
| Goals | 1 | 2017 | 708 | 0.100 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2015 | 277 | 0.100 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 768 | 0.100 |
Why?
|
| Uric Acid | 1 | 2017 | 806 | 0.100 |
Why?
|
| Environmental Monitoring | 2 | 2015 | 1441 | 0.100 |
Why?
|
| Policy | 1 | 2015 | 511 | 0.100 |
Why?
|
| Telomerase | 1 | 2016 | 746 | 0.100 |
Why?
|
| Aircraft | 2 | 2022 | 126 | 0.090 |
Why?
|
| Infant, Newborn | 13 | 2024 | 26181 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 487 | 0.090 |
Why?
|
| Heart Injuries | 1 | 2013 | 208 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 704 | 0.090 |
Why?
|
| ROC Curve | 6 | 2018 | 3568 | 0.090 |
Why?
|
| Crohn Disease | 2 | 2015 | 2275 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2005 | 1190 | 0.090 |
Why?
|
| Monitoring, Physiologic | 2 | 2015 | 1784 | 0.090 |
Why?
|
| Glycolysis | 1 | 2015 | 828 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 358 | 0.090 |
Why?
|
| Psychometrics | 3 | 2017 | 3051 | 0.090 |
Why?
|
| Environment | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Carcinogens | 1 | 2013 | 449 | 0.090 |
Why?
|
| Kidney | 3 | 2019 | 7064 | 0.090 |
Why?
|
| Phenols | 1 | 2014 | 514 | 0.090 |
Why?
|
| Plant Proteins | 2 | 2023 | 370 | 0.090 |
Why?
|
| Estrogen Receptor beta | 2 | 2011 | 168 | 0.090 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 157 | 0.090 |
Why?
|
| Vehicle Emissions | 1 | 2015 | 653 | 0.090 |
Why?
|
| Carbohydrates | 2 | 2023 | 388 | 0.090 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 559 | 0.090 |
Why?
|
| Mental Recall | 4 | 2021 | 1206 | 0.090 |
Why?
|
| Drug Industry | 1 | 1997 | 789 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2008 | 585 | 0.090 |
Why?
|
| Crime Victims | 1 | 2014 | 328 | 0.090 |
Why?
|
| Carbon | 1 | 2014 | 669 | 0.090 |
Why?
|
| Syndrome | 3 | 2018 | 3280 | 0.090 |
Why?
|
| Fibrinolysis | 3 | 2013 | 332 | 0.090 |
Why?
|
| Body Image | 1 | 2015 | 635 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 2128 | 0.090 |
Why?
|
| Fear | 1 | 2019 | 1462 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3804 | 0.090 |
Why?
|
| Plasma | 2 | 2011 | 584 | 0.090 |
Why?
|
| Sex Offenses | 1 | 2014 | 351 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2019 | 4647 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2016 | 1016 | 0.090 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 103 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 369 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2019 | 752 | 0.090 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2022 | 322 | 0.090 |
Why?
|
| Prefrontal Cortex | 2 | 2022 | 2212 | 0.090 |
Why?
|
| Demography | 3 | 2021 | 1650 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4902 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 13630 | 0.080 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2008 | 129 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9585 | 0.080 |
Why?
|
| Gyrus Cinguli | 1 | 2016 | 1114 | 0.080 |
Why?
|
| Troponin T | 1 | 2014 | 774 | 0.080 |
Why?
|
| Anthropometry | 4 | 2006 | 1348 | 0.080 |
Why?
|
| Creatinine | 4 | 2021 | 1903 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2017 | 1261 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2014 | 619 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2010 | 141 | 0.080 |
Why?
|
| Snoring | 2 | 2002 | 206 | 0.080 |
Why?
|
| Brain | 6 | 2023 | 26951 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2015 | 1370 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 995 | 0.080 |
Why?
|
| Publishing | 1 | 1996 | 836 | 0.080 |
Why?
|
| Child | 13 | 2023 | 79806 | 0.080 |
Why?
|
| Social Class | 2 | 2023 | 2005 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 1139 | 0.080 |
Why?
|
| Periodicals as Topic | 2 | 1997 | 1469 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 367 | 0.080 |
Why?
|
| Leiomyoma | 3 | 1998 | 654 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2016 | 2208 | 0.080 |
Why?
|
| Multifactorial Inheritance | 3 | 2023 | 1365 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3865 | 0.080 |
Why?
|
| Zinc | 1 | 2013 | 689 | 0.080 |
Why?
|
| Endpoint Determination | 2 | 2009 | 597 | 0.080 |
Why?
|
| Single-Blind Method | 6 | 2011 | 1578 | 0.080 |
Why?
|
| Africa | 2 | 2021 | 705 | 0.080 |
Why?
|
| Germ-Line Mutation | 3 | 2022 | 1841 | 0.080 |
Why?
|
| Femur | 1 | 2015 | 1302 | 0.080 |
Why?
|
| Mental Disorders | 3 | 2019 | 6796 | 0.080 |
Why?
|
| Emotions | 3 | 2015 | 2734 | 0.080 |
Why?
|
| Blood Coagulation Disorders | 1 | 2011 | 349 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2010 | 344 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 7 | 2005 | 2660 | 0.080 |
Why?
|
| Hip Joint | 1 | 2015 | 1006 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2012 | 2029 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2013 | 665 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1403 | 0.070 |
Why?
|
| Colonic Neoplasms | 5 | 2011 | 2526 | 0.070 |
Why?
|
| Asthma | 3 | 2016 | 6172 | 0.070 |
Why?
|
| Office Visits | 1 | 2012 | 597 | 0.070 |
Why?
|
| TRPM Cation Channels | 1 | 2009 | 139 | 0.070 |
Why?
|
| Mothers | 1 | 2018 | 2186 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1399 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8552 | 0.070 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2008 | 104 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2020 | 1189 | 0.070 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 941 | 0.070 |
Why?
|
| Mental Status Schedule | 3 | 2020 | 314 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2018 | 8035 | 0.070 |
Why?
|
| Pregnancy Proteins | 1 | 2008 | 222 | 0.070 |
Why?
|
| Kaempferols | 1 | 2007 | 21 | 0.070 |
Why?
|
| Yogurt | 2 | 2019 | 71 | 0.070 |
Why?
|
| Asia | 2 | 2020 | 620 | 0.070 |
Why?
|
| Genome, Human | 1 | 2020 | 4417 | 0.070 |
Why?
|
| Brassica | 1 | 2007 | 40 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2023 | 599 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 1860 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2754 | 0.070 |
Why?
|
| Attitude | 2 | 2009 | 777 | 0.070 |
Why?
|
| Glucose Tolerance Test | 3 | 2013 | 1175 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.070 |
Why?
|
| Complement Factor H | 1 | 2007 | 109 | 0.070 |
Why?
|
| Forms and Records Control | 1 | 2007 | 158 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 4 | 2016 | 859 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2016 | 1724 | 0.070 |
Why?
|
| Amenorrhea | 2 | 2023 | 480 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1628 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15697 | 0.070 |
Why?
|
| Prostatic Neoplasms | 5 | 2014 | 11345 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2005 | 364 | 0.070 |
Why?
|
| Biological Specimen Banks | 2 | 2022 | 783 | 0.070 |
Why?
|
| Homosexuality, Female | 2 | 2006 | 159 | 0.070 |
Why?
|
| Liver | 2 | 2012 | 7509 | 0.070 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 793 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 138 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2514 | 0.070 |
Why?
|
| Bisexuality | 2 | 2006 | 274 | 0.070 |
Why?
|
| Heart | 3 | 2022 | 4393 | 0.070 |
Why?
|
| Disclosure | 2 | 2006 | 738 | 0.070 |
Why?
|
| Nootropic Agents | 1 | 2007 | 157 | 0.070 |
Why?
|
| Boston | 8 | 2011 | 9280 | 0.070 |
Why?
|
| Safety | 1 | 2010 | 1148 | 0.070 |
Why?
|
| PPAR gamma | 2 | 2007 | 484 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1287 | 0.060 |
Why?
|
| Visual Acuity | 7 | 2013 | 2643 | 0.060 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 726 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2023 | 8555 | 0.060 |
Why?
|
| Dipeptides | 1 | 2007 | 409 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 1570 | 0.060 |
Why?
|
| Thrombospondins | 1 | 2006 | 193 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2010 | 638 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2010 | 752 | 0.060 |
Why?
|
| Liver Diseases | 2 | 2024 | 1302 | 0.060 |
Why?
|
| Cytokines | 3 | 2017 | 7343 | 0.060 |
Why?
|
| Immune System | 1 | 2010 | 798 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2022 | 640 | 0.060 |
Why?
|
| Uterine Neoplasms | 3 | 1998 | 1439 | 0.060 |
Why?
|
| Canada | 2 | 2022 | 2128 | 0.060 |
Why?
|
| Proline | 2 | 2003 | 457 | 0.060 |
Why?
|
| Vitamin K 1 | 1 | 2005 | 47 | 0.060 |
Why?
|
| Gene Expression | 2 | 2018 | 7588 | 0.060 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 551 | 0.060 |
Why?
|
| Marital Status | 4 | 2012 | 433 | 0.060 |
Why?
|
| Nurse Clinicians | 1 | 2004 | 30 | 0.060 |
Why?
|
| Connective Tissue Diseases | 2 | 1999 | 286 | 0.060 |
Why?
|
| Vitamin A | 3 | 1999 | 613 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7850 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1152 | 0.060 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 478 | 0.060 |
Why?
|
| Central Nervous System Depressants | 2 | 2021 | 164 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2017 | 3258 | 0.060 |
Why?
|
| Causality | 4 | 2016 | 1242 | 0.060 |
Why?
|
| Infant | 5 | 2023 | 36060 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 36290 | 0.060 |
Why?
|
| Dominican Republic | 2 | 2014 | 74 | 0.060 |
Why?
|
| Haplotypes | 5 | 2010 | 2764 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2131 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2012 | 1355 | 0.060 |
Why?
|
| Molecular Weight | 2 | 2020 | 2186 | 0.060 |
Why?
|
| Indonesia | 1 | 2024 | 127 | 0.060 |
Why?
|
| Breast Implants | 2 | 1999 | 410 | 0.060 |
Why?
|
| Type A Personality | 2 | 2001 | 24 | 0.060 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2005 | 152 | 0.060 |
Why?
|
| Lutein | 2 | 2019 | 122 | 0.060 |
Why?
|
| Graves Disease | 1 | 2005 | 239 | 0.060 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.060 |
Why?
|
| Dyspareunia | 2 | 2014 | 48 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2023 | 69 | 0.060 |
Why?
|
| Receptors, Adiponectin | 1 | 2023 | 81 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 2873 | 0.050 |
Why?
|
| Fibrinogen | 3 | 2018 | 886 | 0.050 |
Why?
|
| Anxiety | 4 | 2023 | 4538 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 488 | 0.050 |
Why?
|
| Postprandial Period | 2 | 2020 | 315 | 0.050 |
Why?
|
| Nicotine | 1 | 2008 | 677 | 0.050 |
Why?
|
| Likelihood Functions | 3 | 2014 | 987 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 2 | 2015 | 1174 | 0.050 |
Why?
|
| Sexual Partners | 2 | 2018 | 753 | 0.050 |
Why?
|
| Riboflavin | 2 | 2015 | 105 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4371 | 0.050 |
Why?
|
| Random Allocation | 3 | 2024 | 2394 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2332 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2013 | 2520 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2015 | 3047 | 0.050 |
Why?
|
| Homozygote | 2 | 2007 | 1788 | 0.050 |
Why?
|
| Prealbumin | 1 | 2024 | 222 | 0.050 |
Why?
|
| Contraceptive Agents, Female | 2 | 2017 | 118 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2012 | 6828 | 0.050 |
Why?
|
| Endothelium | 2 | 2005 | 764 | 0.050 |
Why?
|
| Urology | 2 | 2006 | 423 | 0.050 |
Why?
|
| Self Medication | 2 | 2000 | 117 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 961 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2005 | 437 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 445 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2014 | 1724 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 983 | 0.050 |
Why?
|
| Neoplasm Staging | 5 | 2018 | 11152 | 0.050 |
Why?
|
| Histones | 1 | 2012 | 2583 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 655 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Protein C | 2 | 2013 | 133 | 0.050 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2023 | 208 | 0.050 |
Why?
|
| Bulimia | 1 | 2004 | 399 | 0.050 |
Why?
|
| Tooth Loss | 1 | 2004 | 198 | 0.050 |
Why?
|
| Urinalysis | 1 | 2024 | 368 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2021 | 7 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2006 | 553 | 0.050 |
Why?
|
| Airports | 1 | 2021 | 29 | 0.050 |
Why?
|
| Cholelithiasis | 2 | 1994 | 408 | 0.050 |
Why?
|
| Pituitary Hormones | 1 | 2022 | 182 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 1077 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 187 | 0.050 |
Why?
|
| Kidney Diseases | 3 | 2010 | 2093 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2017 | 974 | 0.050 |
Why?
|
| Fructose | 1 | 2023 | 287 | 0.050 |
Why?
|
| Epidemiologic Factors | 1 | 2001 | 36 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2023 | 306 | 0.050 |
Why?
|
| Hemolysis | 1 | 2023 | 423 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2017 | 1754 | 0.050 |
Why?
|
| Lactase | 1 | 2021 | 71 | 0.050 |
Why?
|
| Prothrombin Time | 2 | 2011 | 116 | 0.050 |
Why?
|
| Acute Disease | 4 | 2017 | 7269 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2001 | 204 | 0.050 |
Why?
|
| Asymptomatic Diseases | 2 | 2016 | 587 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 40 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 606 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3539 | 0.050 |
Why?
|
| Sports Medicine | 1 | 2003 | 242 | 0.050 |
Why?
|
| Kynurenine | 1 | 2021 | 139 | 0.050 |
Why?
|
| Codon | 1 | 2002 | 602 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2022 | 167 | 0.050 |
Why?
|
| Creatine | 1 | 2022 | 426 | 0.040 |
Why?
|
| Washington | 2 | 2013 | 312 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 4555 | 0.040 |
Why?
|
| Organ Size | 2 | 2016 | 2254 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2005 | 622 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 4024 | 0.040 |
Why?
|
| Carnitine | 1 | 2021 | 252 | 0.040 |
Why?
|
| Prothrombin | 1 | 2001 | 191 | 0.040 |
Why?
|
| Body Weight Changes | 1 | 1999 | 4 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 2365 | 0.040 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2001 | 132 | 0.040 |
Why?
|
| Drug Interactions | 3 | 2014 | 1428 | 0.040 |
Why?
|
| Phytoestrogens | 1 | 2000 | 59 | 0.040 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.040 |
Why?
|
| Fats | 1 | 2020 | 99 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2192 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1440 | 0.040 |
Why?
|
| Sunscreening Agents | 1 | 2000 | 139 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2004 | 600 | 0.040 |
Why?
|
| Cheese | 1 | 2019 | 38 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2020 | 201 | 0.040 |
Why?
|
| Ultrasonography | 3 | 2011 | 5961 | 0.040 |
Why?
|
| Dizziness | 1 | 2022 | 257 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2015 | 786 | 0.040 |
Why?
|
| Thrombelastography | 2 | 2013 | 183 | 0.040 |
Why?
|
| Health Care Reform | 1 | 2009 | 1245 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2006 | 1207 | 0.040 |
Why?
|
| Verbal Learning | 1 | 2022 | 462 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2014 | 791 | 0.040 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2006 | 734 | 0.040 |
Why?
|
| Plant Preparations | 1 | 2000 | 94 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 1999 | 71 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2005 | 536 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 2897 | 0.040 |
Why?
|
| 24,25-Dihydroxyvitamin D 3 | 1 | 2018 | 8 | 0.040 |
Why?
|
| Running | 2 | 2011 | 483 | 0.040 |
Why?
|
| Tryptophan | 1 | 2021 | 479 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2010 | 1518 | 0.040 |
Why?
|
| Leucine | 1 | 2020 | 547 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2021 | 270 | 0.040 |
Why?
|
| Radiography | 3 | 2016 | 6965 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2007 | 6238 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1216 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2005 | 2255 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2023 | 5785 | 0.040 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2019 | 118 | 0.040 |
Why?
|
| California | 2 | 2020 | 1416 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 350 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10181 | 0.040 |
Why?
|
| Apolipoproteins | 1 | 2020 | 320 | 0.040 |
Why?
|
| Arthralgia | 1 | 2022 | 461 | 0.040 |
Why?
|
| Citrus | 2 | 2013 | 44 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2005 | 867 | 0.040 |
Why?
|
| Nutritive Value | 1 | 2021 | 349 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2022 | 4107 | 0.040 |
Why?
|
| Financing, Government | 2 | 2014 | 472 | 0.040 |
Why?
|
| Health Status Disparities | 2 | 2020 | 1830 | 0.040 |
Why?
|
| Glucuronates | 1 | 2017 | 40 | 0.040 |
Why?
|
| Keratins | 2 | 2015 | 497 | 0.040 |
Why?
|
| Mice | 7 | 2023 | 81208 | 0.040 |
Why?
|
| Patient Participation | 1 | 2007 | 1439 | 0.040 |
Why?
|
| Abortion, Habitual | 1 | 1998 | 61 | 0.040 |
Why?
|
| Ergocalciferols | 1 | 2018 | 110 | 0.040 |
Why?
|
| Starch | 1 | 2018 | 80 | 0.040 |
Why?
|
| Vasculitis | 1 | 2002 | 523 | 0.040 |
Why?
|
| Perception | 2 | 2019 | 1195 | 0.040 |
Why?
|
| SEER Program | 2 | 2013 | 1530 | 0.040 |
Why?
|
| Stearic Acids | 1 | 2017 | 56 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1999 | 177 | 0.040 |
Why?
|
| Factor V | 1 | 1998 | 168 | 0.040 |
Why?
|
| Fatigue | 2 | 2015 | 1544 | 0.040 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 1997 | 85 | 0.040 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 1997 | 86 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 1999 | 250 | 0.040 |
Why?
|
| Colorimetry | 1 | 2017 | 153 | 0.040 |
Why?
|
| Calcitriol | 1 | 2018 | 297 | 0.040 |
Why?
|
| Matched-Pair Analysis | 3 | 2007 | 284 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2019 | 820 | 0.040 |
Why?
|
| Thiamine | 2 | 2011 | 160 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2019 | 251 | 0.040 |
Why?
|
| Psittaciformes | 1 | 2016 | 2 | 0.030 |
Why?
|
| Food, Preserved | 1 | 2016 | 13 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 252 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 1999 | 1032 | 0.030 |
Why?
|
| China | 1 | 2022 | 2339 | 0.030 |
Why?
|
| Purines | 1 | 2020 | 605 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 52 | 0.030 |
Why?
|
| Cotinine | 1 | 2017 | 203 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2013 | 998 | 0.030 |
Why?
|
| Insecticides | 1 | 1997 | 191 | 0.030 |
Why?
|
| Species Specificity | 1 | 2020 | 2418 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1411 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2020 | 626 | 0.030 |
Why?
|
| Mitochondria | 2 | 2020 | 3600 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2003 | 840 | 0.030 |
Why?
|
| Pravastatin | 1 | 2018 | 393 | 0.030 |
Why?
|
| Thrombophlebitis | 2 | 1996 | 288 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 1997 | 235 | 0.030 |
Why?
|
| Medical Records | 5 | 2001 | 1407 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2022 | 1066 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2017 | 437 | 0.030 |
Why?
|
| Parturition | 1 | 2019 | 446 | 0.030 |
Why?
|
| United States Department of Agriculture | 1 | 1995 | 47 | 0.030 |
Why?
|
| Talc | 1 | 2015 | 48 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 565 | 0.030 |
Why?
|
| Endocrinology | 2 | 2012 | 443 | 0.030 |
Why?
|
| Executive Function | 1 | 2023 | 1374 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 976 | 0.030 |
Why?
|
| Chickenpox | 1 | 1995 | 97 | 0.030 |
Why?
|
| Intestinal Absorption | 2 | 2012 | 400 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 5130 | 0.030 |
Why?
|
| Trace Elements | 1 | 2016 | 196 | 0.030 |
Why?
|
| Meditation | 1 | 2018 | 251 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 3 | 2004 | 998 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 1850 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2015 | 278 | 0.030 |
Why?
|
| Mass Media | 1 | 1997 | 300 | 0.030 |
Why?
|
| Cattle | 2 | 2012 | 3847 | 0.030 |
Why?
|
| Gastroenteritis | 1 | 2016 | 237 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2014 | 127 | 0.030 |
Why?
|
| Health Education | 1 | 2000 | 1049 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 2943 | 0.030 |
Why?
|
| Reproduction | 1 | 1998 | 646 | 0.030 |
Why?
|
| Systems Biology | 1 | 2017 | 482 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 788 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 372 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 412 | 0.030 |
Why?
|
| Arm | 1 | 2016 | 583 | 0.030 |
Why?
|
| Telephone | 2 | 2011 | 624 | 0.030 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 14660 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 854 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4000 | 0.030 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2013 | 92 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12965 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 2919 | 0.030 |
Why?
|
| Imidazoles | 1 | 1999 | 1180 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 1628 | 0.030 |
Why?
|
| CA-125 Antigen | 1 | 2015 | 279 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2013 | 151 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 1544 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1931 | 0.030 |
Why?
|
| Mastectomy | 1 | 2021 | 1832 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1997 | 978 | 0.030 |
Why?
|
| Herpes Zoster | 1 | 1995 | 251 | 0.030 |
Why?
|
| Fibrinolysin | 1 | 2013 | 131 | 0.030 |
Why?
|
| Neutron Activation Analysis | 1 | 2012 | 35 | 0.030 |
Why?
|
| Plasminogen Inactivators | 1 | 1992 | 37 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18137 | 0.030 |
Why?
|
| Temperance | 2 | 2003 | 87 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 1387 | 0.030 |
Why?
|
| Urinary Calculi | 1 | 2012 | 91 | 0.030 |
Why?
|
| tau Proteins | 1 | 2023 | 2085 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2017 | 613 | 0.030 |
Why?
|
| Health Services Accessibility | 2 | 2009 | 5397 | 0.030 |
Why?
|
| Brazil | 1 | 2016 | 1218 | 0.030 |
Why?
|
| Data Collection | 2 | 2001 | 3315 | 0.030 |
Why?
|
| Beer | 2 | 2008 | 134 | 0.030 |
Why?
|
| Psychological Tests | 2 | 2007 | 639 | 0.030 |
Why?
|
| Occupational Health | 1 | 1998 | 805 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2012 | 268 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 23376 | 0.020 |
Why?
|
| Health Maintenance Organizations | 2 | 1995 | 660 | 0.020 |
Why?
|
| Wine | 2 | 2008 | 167 | 0.020 |
Why?
|
| Jogging | 1 | 2011 | 18 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2013 | 397 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2017 | 1818 | 0.020 |
Why?
|
| Stereoisomerism | 3 | 2001 | 617 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1997 | 783 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2020 | 1387 | 0.020 |
Why?
|
| Survivors | 1 | 2022 | 2375 | 0.020 |
Why?
|
| Telomere-Binding Proteins | 1 | 2012 | 119 | 0.020 |
Why?
|
| Circadian Rhythm | 2 | 1995 | 2571 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2011 | 29 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2015 | 396 | 0.020 |
Why?
|
| Work Schedule Tolerance | 1 | 1995 | 551 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2015 | 680 | 0.020 |
Why?
|
| Decision Trees | 1 | 2013 | 506 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 3164 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2012 | 507 | 0.020 |
Why?
|
| Transferrin | 1 | 2012 | 284 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 296 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2011 | 99 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 319 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
| Poultry Products | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cefaclor | 1 | 1990 | 8 | 0.020 |
Why?
|
| Penicillin V | 1 | 1990 | 18 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2012 | 221 | 0.020 |
Why?
|
| Fish Products | 1 | 2010 | 29 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Cephalexin | 1 | 1990 | 38 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1895 | 0.020 |
Why?
|
| Serum Sickness | 1 | 1990 | 27 | 0.020 |
Why?
|
| Blood Coagulation Tests | 1 | 2011 | 270 | 0.020 |
Why?
|
| Markov Chains | 1 | 2014 | 968 | 0.020 |
Why?
|
| Eye Diseases | 1 | 2016 | 651 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2013 | 365 | 0.020 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2011 | 866 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2010 | 72 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 207 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 4541 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2199 | 0.020 |
Why?
|
| PubMed | 1 | 2010 | 128 | 0.020 |
Why?
|
| Dancing | 1 | 2011 | 102 | 0.020 |
Why?
|
| Aftercare | 1 | 2016 | 916 | 0.020 |
Why?
|
| Sampling Studies | 1 | 1991 | 613 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2020 | 1234 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 698 | 0.020 |
Why?
|
| Reference Standards | 1 | 2013 | 1004 | 0.020 |
Why?
|
| Bicycling | 1 | 2011 | 176 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Health Occupations | 1 | 2011 | 222 | 0.020 |
Why?
|
| Bronchitis, Chronic | 1 | 2010 | 82 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2008 | 6915 | 0.020 |
Why?
|
| Pulse Therapy, Drug | 1 | 2009 | 36 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 3826 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3832 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 605 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4407 | 0.020 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 292 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2013 | 832 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 154 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 2014 | 738 | 0.020 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1992 | 515 | 0.020 |
Why?
|
| Amoxicillin | 1 | 1990 | 180 | 0.020 |
Why?
|
| Gestational Age | 1 | 2018 | 3565 | 0.020 |
Why?
|
| Alendronate | 1 | 2010 | 173 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 908 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 1529 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 378 | 0.020 |
Why?
|
| Macular Edema | 1 | 2013 | 374 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2018 | 4122 | 0.020 |
Why?
|
| Myocardium | 2 | 2020 | 4700 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2021 | 42063 | 0.020 |
Why?
|
| Binding Sites | 1 | 2017 | 6048 | 0.020 |
Why?
|
| Troponin I | 1 | 2013 | 638 | 0.020 |
Why?
|
| Cost Savings | 1 | 2014 | 920 | 0.020 |
Why?
|
| Religion | 1 | 2012 | 376 | 0.020 |
Why?
|
| Restaurants | 1 | 2011 | 230 | 0.020 |
Why?
|
| Spine | 1 | 2015 | 1111 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2014 | 3531 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 1991 | 486 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1810 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2011 | 742 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 416 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3610 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3682 | 0.020 |
Why?
|
| Libido | 1 | 2008 | 119 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 3016 | 0.020 |
Why?
|
| Cocarcinogenesis | 1 | 2007 | 49 | 0.020 |
Why?
|
| Volition | 1 | 2007 | 62 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 978 | 0.020 |
Why?
|
| Insurance Carriers | 1 | 2009 | 156 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5870 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 6465 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1728 | 0.020 |
Why?
|
| Fetal Development | 1 | 2012 | 766 | 0.020 |
Why?
|
| Xanthophylls | 1 | 2006 | 95 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2022 | 3836 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2326 | 0.020 |
Why?
|
| Anemia | 1 | 2016 | 1511 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3775 | 0.020 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1985 | 29 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 844 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 2012 | 595 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 1022 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 1993 | 987 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 2913 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 784 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 268 | 0.020 |
Why?
|
| Body Size | 1 | 2008 | 462 | 0.020 |
Why?
|
| Lung | 2 | 2016 | 9994 | 0.020 |
Why?
|
| France | 1 | 2007 | 511 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 546 | 0.020 |
Why?
|
| Malus | 1 | 2005 | 50 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 22023 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1985 | 180 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3323 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9276 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2010 | 688 | 0.020 |
Why?
|
| Chromium Compounds | 1 | 2004 | 7 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 1630 | 0.020 |
Why?
|
| Economics, Medical | 1 | 1985 | 112 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5508 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2006 | 641 | 0.010 |
Why?
|
| Government Regulation | 1 | 2009 | 525 | 0.010 |
Why?
|
| Family | 2 | 2012 | 3189 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 2008 | 452 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
| Public Health | 1 | 2017 | 2653 | 0.010 |
Why?
|
| Coronary Artery Bypass | 2 | 2008 | 2272 | 0.010 |
Why?
|
| Propensity Score | 1 | 2012 | 1928 | 0.010 |
Why?
|
| Fabaceae | 1 | 2004 | 103 | 0.010 |
Why?
|
| Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6218 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 2001 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2011 | 1328 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 1231 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 321 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4312 | 0.010 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2004 | 85 | 0.010 |
Why?
|
| Cooking | 1 | 2006 | 311 | 0.010 |
Why?
|
| Heterosexuality | 1 | 2006 | 294 | 0.010 |
Why?
|
| Diuretics | 2 | 1998 | 613 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1985 | 328 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2628 | 0.010 |
Why?
|
| Poverty | 1 | 2015 | 2695 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 2004 | 238 | 0.010 |
Why?
|
| Attention | 1 | 2014 | 2387 | 0.010 |
Why?
|
| Jaw, Edentulous | 1 | 2004 | 99 | 0.010 |
Why?
|
| Urban Population | 1 | 2011 | 2022 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2895 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6068 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1722 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 605 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 291 | 0.010 |
Why?
|
| Trust | 1 | 2007 | 532 | 0.010 |
Why?
|
| Personnel Selection | 1 | 2004 | 193 | 0.010 |
Why?
|
| Politics | 1 | 2009 | 814 | 0.010 |
Why?
|
| Software | 1 | 2016 | 4419 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2007 | 894 | 0.010 |
Why?
|
| Iron Overload | 1 | 2004 | 240 | 0.010 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 1306 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3448 | 0.010 |
Why?
|
| Chlorides | 1 | 2004 | 663 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 5251 | 0.010 |
Why?
|
| Ferritins | 1 | 2004 | 597 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 3446 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2010 | 1801 | 0.010 |
Why?
|
| Hydroxyestrones | 1 | 1999 | 17 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1985 | 733 | 0.010 |
Why?
|
| Periodontal Diseases | 1 | 2004 | 452 | 0.010 |
Why?
|
| Neutrophils | 1 | 2012 | 3767 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 599 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1999 | 143 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1999 | 138 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2006 | 888 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14372 | 0.010 |
Why?
|
| Analgesics | 1 | 2006 | 1065 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1737 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6479 | 0.010 |
Why?
|
| Diarrhea | 1 | 1985 | 1319 | 0.010 |
Why?
|
| Phytotherapy | 1 | 2001 | 295 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 2557 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 2536 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16939 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2006 | 2435 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4466 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1257 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2421 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2006 | 1194 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2819 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5794 | 0.010 |
Why?
|
| Nursing Staff | 1 | 1998 | 113 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2758 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1345 | 0.010 |
Why?
|
| Biometry | 1 | 1999 | 559 | 0.010 |
Why?
|
| Housing | 1 | 2001 | 665 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11071 | 0.010 |
Why?
|
| Teaching | 1 | 2004 | 1169 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 23711 | 0.010 |
Why?
|
| Morbidity | 1 | 2001 | 1765 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 928 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 1994 | 31 | 0.010 |
Why?
|
| Thrombosis | 1 | 2009 | 3052 | 0.010 |
Why?
|
| Acetylation | 1 | 1997 | 1062 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 2092 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1994 | 78 | 0.010 |
Why?
|
| General Surgery | 1 | 2006 | 1678 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1995 | 450 | 0.010 |
Why?
|
| Hydrogenation | 1 | 1993 | 20 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2006 | 2363 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1993 | 104 | 0.010 |
Why?
|
| Anger | 1 | 1995 | 401 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 1594 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1998 | 1259 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1991 | 23 | 0.010 |
Why?
|
| Arteries | 1 | 1997 | 1126 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1523 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 12446 | 0.010 |
Why?
|
| Selection Bias | 1 | 1993 | 358 | 0.010 |
Why?
|
| Biological Transport | 1 | 1995 | 2086 | 0.010 |
Why?
|
| Lymphoma | 1 | 1999 | 1898 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 1992 | 406 | 0.010 |
Why?
|
| HIV Infections | 1 | 2016 | 17165 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1991 | 691 | 0.010 |
Why?
|
| Disabled Persons | 1 | 1998 | 1223 | 0.000 |
Why?
|
| Pharyngitis | 1 | 1990 | 220 | 0.000 |
Why?
|
| Information Systems | 1 | 1990 | 398 | 0.000 |
Why?
|
| Otitis Media | 1 | 1990 | 285 | 0.000 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 1039 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1991 | 1690 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1990 | 617 | 0.000 |
Why?
|
| Pseudopregnancy | 1 | 1985 | 10 | 0.000 |
Why?
|
| Munchausen Syndrome | 1 | 1985 | 19 | 0.000 |
Why?
|
| Absorption | 1 | 1985 | 243 | 0.000 |
Why?
|
| Insulin, Long-Acting | 1 | 1985 | 58 | 0.000 |
Why?
|
| Surface-Active Agents | 1 | 1985 | 150 | 0.000 |
Why?
|
| Administration, Intranasal | 1 | 1985 | 471 | 0.000 |
Why?
|
| Apoptosis | 1 | 1998 | 9501 | 0.000 |
Why?
|
| Aerosols | 1 | 1985 | 632 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 2558 | 0.000 |
Why?
|
| Nasal Mucosa | 1 | 1985 | 412 | 0.000 |
Why?
|
| Conversion Disorder | 1 | 1985 | 202 | 0.000 |
Why?
|
| Angiography | 1 | 1985 | 1605 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1985 | 1189 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1985 | 1913 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1992 | 7818 | 0.000 |
Why?
|